Monopar Therapeutics (MNPR) Earnings (2017 - 2026)
Monopar Therapeutics (MNPR) earnings from Mar 31, 2017 to Mar 31, 2026. The TTM Monopar Therapeutics (MNPR) earnings is -$15M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Monopar Therapeutics (MNPR) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -9.60% |
| 3 Years TTM | +12.61% |
| 5 Years TTM | +16.10% |
| All Time TTM | -1.61% |
Annual Earnings change of Monopar Therapeutics (MNPR)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$3.89M | -71.65% |
| 2025 | -$14M | -11.99% |
| 2024 | -$16M | +85.60% |
| 2023 | -$8.40M | -20.15% |
| 2022 | -$11M | +15.60% |
| 2021 | -$9.10M | +44.44% |
| 2020 | -$6.30M | +49.29% |
| 2019 | -$4.22M | +30.65% |
| 2018 | -$3.23M | -80.48% |
| 2017 | -$17M | +1290.76% |
| 2016 | -$1.19M | N/A |
Comparison Monopar Therapeutics (MNPR) five years earnings CAGR with competitors
Monopar Therapeutics (MNPR) five years earnings CAGR is 16.12%.